CCA
ISEE

Checchi Capital Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Checchi Capital Advisers’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7
Closed – – 1294
2016
Q2 		$0 Hold
7
– – ﹤0.01% 1647
2016
Q1 		$0 Buy
+7
New +$357 ﹤0.01% 1622

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Checchi Capital Advisers's ISEE Position: Q3 2016 in Review

Checchi Capital Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2016, closing a stake of 7 shares.

Checchi Capital Advisers first reported a position in ISEE in Q1 2016 and held it in 2 quarters. The position peaked at $0 in Q2 2016. 192 funds tracked by Wall St. Rank hold ISEE as of Q3 2016.

  • Checchi Capital Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 7 IVERIC bio, Inc. Common Stock shares in Q3 2016.
  • Checchi Capital Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's IVERIC bio, Inc. Common Stock position peaked at $0 in Q2 2016.
  • 192 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.